Home FDA labels 0acd8136-06dc-4ea4-e063-6394a90a5b51 Hydrocortisone Acetate openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name Hydrocortisone Acetate
Generic name HYDROCORTISONE ACETATE
Manufacturer Cosette Pharmaceuticals, Inc.
Product type HUMAN PRESCRIPTION DRUG
SPL set ID c84ab549-1d5c-4646-a041-6cb571812ad8
SPL ID 0acd8136-06dc-4ea4-e063-6394a90a5b51
Version 2
Effective date 2023-11-23
Source export date 2026-10-27
Source partition 7
Source file https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-27/be847f9aea8d80a2cb7e9771acd1143be084664192ecf8f5be8ac1024116f4f0/drug-label-0007-of-0014.json.zip
Source manifest SHA-256 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run 20261027T193451Z
Imported at 2026-10-27 20:12:25 Harmonized routes table Harmonized routes RECTAL
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 10 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 1 matching rows.
adverse reactions ADVERSE REACTIONS The following local adverse reactions have been reported with Hydrocortisone Acetate Suppositories: 1. Burning 5. Folliculitis 2. Itching 6. Hypopigmentation 3. Irritation 7. Allergic Contact Dermatitis 4. Dryness 8. Secondary Infection To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.